As of 2025-09-18, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -9.89 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.47 USD, the upside of Solid Biosciences Inc is -280.87%.
Based on its market price of 5.47 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 280.87%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.89 - -9.89 | -9.89 | -280.87% |
| P/E | (13.53) - (22.83) | (17.26) | -415.6% |
| DDM - Stable | (17.81) - (67.11) | (42.46) | -876.3% |
| DDM - Multi | (0.24) - (0.68) | (0.35) | -106.4% |
| Market Cap (mil) | 425.95 |
| Beta | 1.99 |
| Outstanding shares (mil) | 77.87 |
| Enterprise Value (mil) | 287.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.22% |
| Cost of Debt | 5.00% |
| WACC | 9.20% |